Carroll Financial Associates’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-320,000
| Closed | -$572K | – | 1763 |
|
|
2021
Q1 | $572K | Sell |
320,000
-125,000
| -28% | -$223K | 0.04% | 234 |
|
|
2020
Q4 | $694K | Sell |
445,000
-70,000
| -14% | -$109K | 0.05% | 195 |
|
|
2020
Q3 | $535K | Hold |
515,000
| – | – | 0.04% | 210 |
|
|
2020
Q2 | $308K | Buy |
515,000
+300,000
| +140% | +$179K | 0.03% | 276 |
|
|
2020
Q1 | $105K | Hold |
215,000
| – | – | 0.01% | 412 |
|
|
2019
Q4 | $135K | Hold |
215,000
| – | – | 0.01% | 440 |
|
|
2019
Q3 | $208K | Hold |
215,000
| – | – | 0.02% | 355 |
|
|
2019
Q2 | $352K | Buy |
+215,000
| New | +$352K | 0.03% | 254 |
|
|
2019
Q1 | – | Sell |
-216,000
| Closed | -$82K | – | 1420 |
|
|
2018
Q4 | $82K | Buy |
216,000
+1,000
| +0.5% | +$380 | 0.01% | 411 |
|
|
2018
Q3 | $1.39M | Buy |
+215,000
| New | +$1.39M | 0.15% | 96 |
|